![Todd Simpson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Todd Simpson
Direktor/Vorstandsmitglied bei
XENCOR, INC.
Vermögen: - $ am 31.05.2026
Profil
Gegenwärtig ist Todd E. Simpson Chairman für Neoleukin Therapeutics, Inc. und Chief Financial Officer für Seagen Inc. Herr Simpson ist auch im Vorstand von Cascadian Therapeutics, Inc. und der Washington Biotechnology & Biomedical Association. In seiner früheren Laufbahn hatte er die Position des CFO, VP-Finance & Administration bei Vericel Corp. inne, Treasurer bei Integra LifeSciences Holdings Corp. und Chief Financial Officer & Vice President von Telios Pharmaceuticals, Inc. (eine Tochtergesellschaft von Integra LifeSciences Holdings Corp.), CFO & VP-Finance & Administration bei AmpliPhi Biosciences Corp. und Principal bei Ernst & Young LLP. Er erhielt einen Bachelor-Abschluss von der Oregon State University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
XENCOR, INC. -.--% | 28.02.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktuelle Nachrichten zu Todd Simpson
Aktive Positionen von Todd Simpson
| Unternehmen | Position | Beginn |
|---|---|---|
| XENCOR, INC. | Direktor/Vorstandsmitglied | 13.03.2025 |
Shape Therapeutics, Inc.
 Shape Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel, small molecule, topical histone deacetylase inhibitor for the treatment of cutaneous t-cell lymphoma | Direktor/Vorstandsmitglied | 25.06.2024 |
Inovia Capital (US), Inc.
 Inovia Capital (US), Inc. Investment ManagersFinance Functions as an alternative investment manager | Berater | 01.01.2017 |
Ehemalige bekannte Positionen von Todd Simpson
| Unternehmen | Position | Ende |
|---|---|---|
| SEAGEN INC. | Finanzdirektor/CFO | 14.12.2022 |
AmpliPhi Biosciences Corp.
 AmpliPhi Biosciences Corp. BiotechnologyHealth Technology Develops and commercializes novel bacteriophage-based therapeutics | Finanzdirektor/CFO | 01.10.2005 |
AmpliPhi Biosciences Corp.
AmpliPhi Biosciences Corp. BiotechnologyHealth Technology Develops and commercializes novel bacteriophage-based therapeutics | Finanzdirektor/CFO | 01.10.2001 |
| VERICEL CORPORATION | Finanzdirektor/CFO | 01.10.2001 |
| INTEGRA LIFESCIENCES HOLDINGS CORPORATION | Treasurer | 01.12.1995 |
Ausbildung von Todd Simpson
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
86
Beziehungen ersten Grades
15
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 15 |
|---|---|
Telios Pharmaceuticals, Inc.
 Telios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Pharmaceuticals, research | Health Technology |
AmpliPhi Biosciences Corp.
AmpliPhi Biosciences Corp. BiotechnologyHealth Technology Develops and commercializes novel bacteriophage-based therapeutics | Health Technology |
Integra LifeSciences Holdings Corp.
 Integra LifeSciences Holdings Corp. Medical SpecialtiesHealth Technology Develops, manufactures and markets medical devices, implants and biomaterials | Health Technology |
Vericel Corp.
 Vericel Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which manufactures and markets two advanced cell therapy products for sports medicine and severe burn care | Health Technology |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Seagen, Inc.
 Seagen, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody-based therapeutic products for treatment of cancer and immunologic diseases | Health Technology |
Xencor, Inc.
 Xencor, Inc. BiotechnologyHealth Technology Develops therapeutics to treat autoimmune and allergic diseases, cancer and other conditions | Health Technology |
Cascadian Therapeutics LLC
 Cascadian Therapeutics LLC Medical SpecialtiesHealth Technology Develops therapeutic products for the treatment of cancer | Health Technology |
Oregon State University
 Oregon State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Washington Biotechnology & Biomedical Association
 Washington Biotechnology & Biomedical Association Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit trade association that supports and promotes the life sciences industry | Commercial Services |
Aquinox Pharmaceuticals, Inc.
 Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in identification and development of therapeutics for inflammatory diseases and cancer | Health Technology |
Inovia Capital (US), Inc.
Inovia Capital (US), Inc. Investment ManagersFinance Functions as an alternative investment manager | Finance |
Shape Therapeutics, Inc.
Shape Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel, small molecule, topical histone deacetylase inhibitor for the treatment of cutaneous t-cell lymphoma | Health Technology |
Neoleukin Therapeutics, Inc. /old/
 Neoleukin Therapeutics, Inc. /old/ Pharmaceuticals: MajorHealth Technology Develops medicines that transform lives | Health Technology |
Neoleukin Therapeutics, Inc.
 Neoleukin Therapeutics, Inc. BiotechnologyHealth Technology Develops de novo – therapeutic proteins to treat serious immunological disorders, including cancer and autoimmunity | Health Technology |
